-
Company Insights
NewMDxHealth SA Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our MDxHealth SA Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment, and the personalized treatment of patients. The company’s product portfolio includes ConfirmMDx, an epigenetic assay that detects the epigenetic effect of cancer; SelectMDx, a liquid biopsy assay for prostate cancer. MdxHealth tests are based on MSP (Methylation-Specific polymerase chain reaction) technology, a proprietary DNA-based platform....
-
Product Insights
New![]()
Oncoradiomics SA Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Oncoradiomics SA Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Oncoradiomics SA (Radiomics) is an imaging research organization focusing on accurate diagnostics, detailed therapy evaluation, and sensitive prediction of treatment effects in oncology and other therapeutic areas. The company focuses on AI-powered healthcare, with unique expertise in Radiomics, Deep Learning, and Federated Learning applied to oncology and other therapeutic areas. It also carries out advanced image analysis technology which separates...
-
Product Insights
New![]()
Arterial Thrombosis – Drugs In Development, 2024
Empower your strategies with our Arterial Thrombosis – Drugs In Development, 2024 report and make more profitable business decisions. Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale skin, and coldness. Depending on where the clot forms, arterial thrombosis can cause several serious conditions, including stroke, heart attack, and peripheral arterial disease (PAD). Predisposing factors include smoking, obesity, diabetes, hypertension, and high cholesterol level. Treatment includes thrombolytic...
-
Product Insights
New![]()
Thromboembolism – Drugs In Development, 2024
Empower your strategies with our Thromboembolism – Drugs In Development, 2024 report and make more profitable business decisions. A thromboembolism occurs when a blood clot (thrombus) break and travels in the bloodstream. Symptoms include warmth, edema, and erythema, and may also include dilated veins (collaterals) on the chest wall or leg. Risk factors include hypertension, diabetes mellitus, cigarette smoking, and high cholesterol levels. Treatment includes anticoagulants, thrombolytic therapy, and surgery. The Thromboembolism drugs in development market research report provide comprehensive information...
-
Product Insights
New![]()
Thrombosis – Drugs In Development, 2024
Empower your strategies with our Thrombosis – Drugs In Development, 2024 report and make more profitable business decisions. Thrombosis is the formation of a blood clot, known as a thrombus, within a blood vessel. This clot can obstruct the normal blood flow, potentially leading to various health complications. Thrombosis can occur in both veins and arteries. Common types include Deep Vein Thrombosis (DVT), where clots form in deep veins, often in the legs, and Pulmonary Embolism (PE), which occurs when a...
-
Product Insights
![]()
Monsin
Monsin is a hydro project located in Liege, Belgium. The project is owned by Luminus SA. The project came online in 1954. Empower your strategies with our Monsin report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and...
-
Product Insights
![]()
Lixhe
Lixhe is a hydro project located in Liege, Belgium. The project is owned by Electricite de France SA. The project came online in 1980. Empower your strategies with our Lixhe report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data...
-
Product Insights
![]()
Ampsin-Neuville
Ampsin-Neuville is a hydro project located in Liege, Belgium. The project is owned by Electricite de France SA. The project came online in 1965. Empower your strategies with our Ampsin-Neuville report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data...
-
Product Insights
![]()
Biowanze Biomass Power Plant
Biowanze Biomass Power Plant is a biopower project located in Liege, Belgium. The project came online in 2009. Empower your strategies with our Biowanze Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance....
-
Product Insights
![]()
Coo-Trois Ponts
Coo-Trois Ponts is a hydro project located in Liege, Belgium. The project is owned by Electrabel SA. The project came online in 1972. Empower your strategies with our Coo-Trois Ponts report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.